Table 6.
Toxin/ Molecule |
Species | Production | Administration | Mechanism of Analgesia | Model | Ref. |
---|---|---|---|---|---|---|
Im10A (conotoxin) | Conus imperialis | Synthesized | Intramuscular injection (i.m.) |
- | Rat PNL model | [131] |
μ-Conotoxin TsIIIA | Conus tessulatus | Synthesized | Intrathecal (i.t.) injection | Inhibition of TTX (tetrodotoxin)-resistant sodium currents in DRG neurons | Hot-plate model | [132] |
α-Conopeptide Eu1.6 | Conus eburneus | Synthesized | Intramuscular injection (i.m.) and intravenous (i.v.) injection |
Inhibition of high voltage-activated N-type calcium channel currents (Cav2.2) in isolated mouse dorsal root ganglia (DRG) neurons | Rat partial sciatic nerve injury (PNL model) and chronic constriction injury pain (CCI model) models | [102] |
ω-Conotoxins: MoVIA and MoVIB |
Conus
Moncuri |
Purified from venom and synthesized |
Intrathecal (i.t.) injection | Inhibition of rat Cav2.2 channels | PNL-induced neuropathic pain | [134] |
α-Conotoxin Vc1.1 Variants | - | Synthesized | Intramuscular (im.i), injection | Inhibition of G protein-coupled γ-aminobutyric acid type B receptors (GABABR) coupled Cav2.2 channels in rat DRG neurons | PNL and CCI models | [135] |
cVc1.1 and cVc1.1 analogues: [C2H, C8F]cVc1.1 and [N9W]cVc1.1 | - | Synthesized | Intra-colonic administration | Reduction in the excitability of DRG neurons | Chronic visceral hypersensitivity (CVH model) | [142] |
ω -Conotoxin MVIIA modified | - | Synthesized | Intravenously (i.v.) injection and intranasally injection |
- | Hot-Plate model | [144] |
αO-Conotoxin GeXIVA | Conus generalis | Synthesized | Intramuscular (im.i), injection | - | Oxaliplatin-induced neuropathic pain, cold and mechanical allodynia | [137] |
Partially purified conotoxins (C1-C7) of C. coronatus and C. frigidus (F1-F6). | Conus coronatus and Conus frigidus | Purified from Venom |
Intraperitoneal (i.p.) injection |
Only C2 had analgesic effects in both tested models; mechanism of analgesia: not studied | Hot-plate model and formalin-induced pain | [145] |
BuIA conotoxin analogues | Conus bullatus | Synthesized | Intraperitoneal (i.p.) injection |
All the analogs showed the same analgesic activity of BuIA Mechanism of analgesia: not studied |
Hot-plate model and paclitaxel-induced neuropathic pain | [138] |
ω-conotoxin Bu8 | Conus bullatus | Synthesized | Intraperitoneal (i.p.) injection |
Inhibition of Cav2.2 | Hot-plate model and analgesic activity to acute pain and inflammatory pain | [146] |
Conotoxin-Ac1// Conotoxin-Ac1-O6P (variant) |
Conus achatinus | Synthesized | Intrathecal (i.t.) injection | Inhibition of NR2B ion channels | Hot-plate and tail-flick models | [141] |
α-Conotoxin Vc1.1 modified | Conus victoriae | Purified from venom and modified |
Intramuscular (im.i), injection | Activation of GABABRs expressed in DRG | Spinal nerve ligation-induced neuropathic pain (SNL model), mechanical allodynia | [136] |
α4/7-Conotoxin (Lv1d) | Conus lividus | Synthesized | Intrathecal (i.t.) injection (mouse hot plate model) Intramedullary injection (formalin-induced pain model) |
- | Mouse hot-plate and formalin-induced pain models | [147] |
µ-Conotoxin S24a | Conus striatus | Synthesized | Intrathecal (i.t.) injection | - | Mouse hot-plate and formalin-induced pain models | [148] |
ω-Conotoxin | Conus virgo | Purified from venom and modified |
Intraperitoneal (i.p.) injection |
- | Central analgesic assay (tail immersion test) and Peripheral analgesic assay (acetic acid-induced writhing test) | [149] |
α-CTx RgIA analogues (RgIA-5524) |
- | Synthesized | Subcutaneous (i.s.) injection |
Inhibition of α9-containing nicotinic acetylcholine receptors (nAChRs) | Oxaliplatin-induced neuropathic pain | [143] |
α-Conotoxin RgIA analogues (RgIA-5474) | - | Synthesized | Subcutaneous (i.s.) injection |
- | Oxaliplatin-induced neuropathic pain, cold allodynia | [139] |
ω–Conotoxins: MVIIA, GVIA and CVIF | - | Obtained from Alomone Labs (Jerusalem, Israel). |
Intraplantar (i.pl.). injection | - | Post-surgical pain (PSP model) and cisplatin-induced pain neuropathy and oxaliplatin-induced neuropathic pain | [140] |